Pyoderma gangrenosum: An overview

Plastic Surgical Nursing

Volumn 28, Issue 3, 2008, Pages 154-157

  Spear, Marcia ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; HUMAN; MALE; PATHOPHYSIOLOGY; PYODERMA GANGRENOSUM; REVIEW;

ADULT; HUMANS; MALE; PYODERMA GANGRENOSUM;

EID: 58949098026     PISSN: 07415206     EISSN: 15501841     Source Type: Journal    
DOI: 10.1097/01.PSN.0000335820.07659.6f     Document Type: Article

References (26)

1. Adachi, Y., Kindzelskii, A. L., Cookingham, G., Shaya, S., Moore, E. C., Todd, R. F., et al. (1998). Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. Journal of Investigative Dermatology. 111(2), 259-268.
2. Bennett, M., Jackson, J., Jorizzo, J., Fleis cher, A., White, W., & Callen, J. (2000). Pyoderma gangrenosum. A compari son of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine, 79, 37-46.
3. Braun, M. (1982). Pyoderma gangreno sum. Dermatology, 28, 28-42.
4. Brooklyn, T., Dunnill, G., & Probert, C. (2006). Diagnosis and treatment of pyoderma gangrenosum. British Medical Journal, 333, 181-184.
5. Brooklyn, T. N., Dunnill, M. G., Shetty, A., Bowden, J., Williams, J. D., Griffiths, C. E., et al. (2006). Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial. Gastroenterology, 55(4), 505-509.
6. Brunsting, L. A., Goeckerman, W. H., & O'Leary, P. A. (1930). Pyoderma (ecthyma) gangrenosum: Clinical experimental observation in five cases occurring in adults. Archives of Dermatology and Syphilology, 22, 655-680.
7. Hammond, D. C., Simon, A. M., Kuthaila, D., & Andres, A. (2006). Pyoderma gangrenosum following reduction mammaplasty. Canadian Journal of Plastic Surgery, 14(1), 37-40.
8. Harris, A., Regan, P., & Burge, S. (1998). Lesson of the week: Early diagnosis of pyoderma gangrenosum is important to prevent disfigurement. British Medical Journal, 316, 52-53.
9. Holt, P. J. A., Davies, M. G., Saunders, K. C., & Nuki, G. (1980). Pyoderma gangrenosum: Clinical and laboratory findings in 15 patients with special references to polyarthritis. Medicine, 59, 114-144.
10. Hughes, A., Jackson, J., & Callen, J. (2000). Clinical features and treatment of peristomal pyoderma gangrenosum. The Journal of the American Medical Association, 284, 1546-1548.
11. Jacob, S. E., Weisman, R. S., & Kerdel, A. (2008). Pyoderma gangrenosum- rebel without a cure? International Journal of Dermatology. 47(2), 192-194.
12. Kelly, J. (2001). Pyoderma gangraenosum: Exploring the treatment options. Journal of Wound Care, 10, 125-128.
13. Lifchez, S., & Larson, D. (2002). Pyoderma gangrenosum after reduction mammaplasty in an otherwise healthy patient. Annals of Plastic Surgery, 49(4), 410-413.
14. Marzano, A., Tourlaki, A., Alessi, E., & Caputo, R. (2008). Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: A 10-year history with response to infliximab. Clinical and Experimental Dermatology, 33(2), 156-159.
15. Meyer, N., Ferraro, V., Mignard, M., Adamski, H., & Chevrant-Breton, J. (2006). Pyoderma gangrenosum treated with high-dose intravenous immunoglobulins: Two cases and review of the literature. Clinical Drug Investigation, 26(9), 541-546.
16. Okuma, K., Mitsuishi, K., Hasegawa, T., Tsuchihashi, H., Ogawa, H., & Ikeda, S. (2007). A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis. Therapeutic Apheresis and Dialysis. 11(5), 387-390.
17. Perry, H. O., & Brunstring, L. A. (1957). Pyoderma gangrenosum: A clinical study of nineteen cases. Archives of Dermatology, 75, 380-387.
18. Powell, F. C., Su, W. P. D., & Perry, H. O. (1996). Pyoderma gangrenosum: Classification and management. Journal of the American Academy of Dermatology, 34, 395-409.
19. Reguiai, Z., & Grange, F. (2007). The role of anti-tumor necrosis factor-alpha therapy in pyoderma gangrenosum associated with inflammatory bowel disease. American Journal of Clinical Dermatology, 8(2), 67-77.
20. Reichrath, J., Bens, G., Bonowitz, A., & Tilgen, W. (2005). Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients. Journal of the American Academy of Dermatology, 53(2), 273-283.
21. Robert, C., & Kupper, T. (1999). Inflammatory skin diseases, T cells, and immune surveillance. New England Journal of Medicine, 341, 1817-1828 .
22. Rozen, S. M., Nahabedian, M. Y., & Manson, P. N. (2001). Management strategies for pyoderma gangrenosum: Case studies and review of literature. Annals of Plastic Surgery, 47(3), 310-315.
23. Snyder, R. (1986). Pyoderma gangrenosum involving the head and neck. Archives of Dermatology. 122, 295-302.
24. Van Poucke, S. V., Jorens, P. G., Peeters, R., Jacobs, W., Beeck, B. O., Lambert, J., et al. (2004). Pyoderma gangrenosum: A challenging complication of bilateral mastopexy. International Wound Journal, 1(3), 207-213.
25. Weenig, R., Davis, M., Dahl, P., & Su, W. P. (2002). Skin ulcers misdiagnosed as pyoderma gangrenosum. The New England Journal of Medicine, 347, 1412-1418.
26. Wollina, U. (2002). Clinical management of pyoderma gangrenosum. American Journal of Clinical Dermatology, 3(3), 149-158. Retrieved April 11, 2008, from www.emedicine.com/